Developing Differentiated Therapeutics Improving Overall Quality of Life for People Living with Neurodegenerative and Neurodevelopmental Disorders

We are delighted to announce that Dr. Christopher Missling, the President and CEO of Anavex Life Sciences, will be the featured speaker at our upcoming MSQ Webinar Series co-hosted by MSQ Ventures and BioAroundWorld on April 26th. The webinar's theme is "Developing Differentiated Therapeutics Improving Overall Quality of Life for People Living with Neurodegenerative and Neurodevelopmental Disorders."  

Guest Speaker: Dr. Christopher Missling President & CEO, Anavex Life Sciences  

Moderator: Echo Hindle-Yang, President & CEO, MSQ Ventures   

Date: Wednesday, April 26th, 2023 

Time: 9pm – 10pm BJT 

          9am – 10am ET 

Register Here: https://lnkd.in/evaEt9D4  

* After the webinar, attendees will have an opportunity to set up a 1-1 session with the guest speaker post event via MSQ